In vitro studies have identified that GBM cells with a highly endogenous expression of RANKL stimulate astrocyte activation through the NF-κB signalling pathway, which secreted various growth factors, including TGF-β, facilitating GBM cell invasiveness [76]. Here, NFKB1 is linked to glioblastoma.